ONVO Organovo Holdings Inc

Organovo Holdings Inc is a development-stage company. It is engaged in developing and commercializing functional three-dimensional human tissues.

As of 04/09/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/14/2012
Outstanding shares:  7,117,083
Average volume:  149,239
Market cap:   $66,544,726
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68620A203
ISIN:        US68620A2033
Sedol:      BN2C1T0
Valuation   (See tab for details)
PE ratio:   -7.44
PB ratio:   42.12
PS ratio:   0.00
Return on equity:   -81.69%
Net income %:   -169,530,000,000.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy